Navigation Links
Yale and Rush University scientists receive Sanberg Awards from ASNTR

Tampa, Fla. (May 9, 2011) At the 18th Annual Conference of the American Society of Neural Therapy and Repair (ASNTR), held in conjunction with the 11th International Conference on Neuronal Transplantation and Repair (INTR) May 4 May 8, 2011 in Clearwater Beach, Florida, the ASNTR awarded The 2011 Bernard Sanberg Memorial Award for Brain Repair to Donald Eugene Redmond, MD, professor of neurosurgery, Yale University School of Medicine. ASNTR also presented The Molly and Bernard Sanberg Memorial Award to Roy E.A. Bakay, MD, professor and vice chairman of the Department of Neurological Surgery, Rush University Medical Center.

The 2011 Bernard Sanberg Memorial Award for Brain Repair

The 2011 award was presented in recognition of Dr. Redmond's significant and lifelong research and clinical contributions in neurosurgery.

The award is named for Bernard Sanberg, father of Dr. Paul Sanberg (University of South Florida), who is a co-founder of the ASNTR. After Bernard Sanberg died of a stroke in 1999, the award bearing his name was established and is presented by the ASNTR annually to an individual who has made outstanding research contributions in the field of neural therapy and repair. The award, first presented in 2000, is presented every year at ASNTR's Annual Meeting.

Research interests for Dr. Redmond, who has a joint appointment in the Departments of Psychiatry and Neurosurgery, include dopamine, fetal neural tissue, stem cells, gene therapy, neural grafts and Parkinson's disease. He also serves as the director of Yale University Medical School's Neural Transplant and Neurobehavior Program where Yale scientists investigate cellular and viral repair strategies for central nervous system diseases.

"Gene is an outstanding scientist who had the insight to recognize the need for establishing a state-of-the-art primate research facility," said Dr. Robert Roth, professor of pharmacology and psychiatry, Yale University School of Medicine. "The St. Kitts Biomedical Foundation, which Gene founded and directs, is an AAALAC accredited facility and recognized as one the premier primate research facilities in the world. It is utilized by numerous outstanding scientists who are recognized nationally and internationally for their translational research on neurodegenerative disorders. I and the members of ASNTR owe Gene a debt of gratitude for establishing and directing a world class site for translational research. He is most deserving of the this award."

According to Dr. John Sladek, professor of neurology, pediatrics and neuroscience at the University of Colorado School of Medicine, Dr. Redmond has led the field of cellular repair in the nervous system for Parkinson's disease for over 25 years and pioneered the use of a non-human primate model of the disease. "Excellence in academia is, perhaps, not surprising for this former high school Class Valedictorian (Thomas Jefferson San Antonio) and member of Phi Bet Kappa (Southern Methodist University)," said Dr. Sladek. "He is one of the founding members the ASNTR and has provided thoughtful guidance for the Society's position on clinical trials."

Recent past winners of the award include Shinn-Zong Lin, MD, PhD (2010) Howard J. Federoff, MD, PhD, Georgetown University (2009); Paul Carvey, PhD, Rush University Medical Center (2008); Barry Hoffer, MD, PhD, NIDA/NIH (2007); and John Sladek, PhD, University of Colorado (2006).

The Molly and Bernard Sanberg Memorial Award

In recognition of his significant contributions to the field of brain repair, this year's Molly and Bernard Sanberg Memorial Award was presented to Roy A.E. Bakay, MD, professor and vice chairman of the Department of Neurological Surgery, Rush University Medical Center.

The Molly and Bernard Sanberg Memorial Award is presented periodically by the ASNTR to an outstanding scientist who has made a significant contribution to the field of brain repair.

Dr. Bakay's clinical interests include stereotaxy, epilepsy, movement disorders and brain tumors while his research interests range from neuroanatomical to electrophysical. His early efforts were directed at evaluating neuroanatomical changes in the development of epilepsy. Currently, he focuses on neural transplantation and neurotrophic gene therapy.

"Dr. Roy Bakay has been a leading clinician and scientist for decades," said Dr. Jeffery H. Kordower, director of the Research Center for Brain Repair and section head for neurosurgery at the Rush University Medical Center. "He was first to demonstrate survival of dopamine grafted neurons in nonhuman primates and has been a leader in clinical work with fetal transplants, DBS, gene therapy and other neurosurgical approaches."


Contact: Donna Morrison
University of South Florida (USF Health)

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: